7-83385314-G-A
Position:
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_012431.3(SEMA3E):c.1855C>T(p.Arg619Cys) variant causes a missense change. The variant allele was found at a frequency of 0.000179 in 1,612,944 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Genomes: 𝑓 0.00014 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00018 ( 0 hom. )
Consequence
SEMA3E
NM_012431.3 missense
NM_012431.3 missense
Scores
6
13
Clinical Significance
Conservation
PhyloP100: 5.03
Genes affected
SEMA3E (HGNC:10727): (semaphorin 3E) Semaphorins are a large family of conserved secreted and membrane associated proteins which possess a semaphorin (Sema) domain and a PSI domain (found in plexins, semaphorins and integrins) in the N-terminal extracellular portion. Based on sequence and structural similarities, semaphorins are put into eight classes: invertebrates contain classes 1 and 2, viruses have class V, and vertebrates contain classes 3-7. Semaphorins serve as axon guidance ligands via multimeric receptor complexes, some (if not all) containing plexin proteins. This gene encodes a class 4 semaphorin. This gene encodes a class 3 semaphorin. Multiple transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, May 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -6 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.14716998).
BS2
High AC in GnomAd4 at 21 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SEMA3E | NM_012431.3 | c.1855C>T | p.Arg619Cys | missense_variant | 16/17 | ENST00000643230.2 | NP_036563.1 | |
SEMA3E | NM_001178129.2 | c.1675C>T | p.Arg559Cys | missense_variant | 16/17 | NP_001171600.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SEMA3E | ENST00000643230.2 | c.1855C>T | p.Arg619Cys | missense_variant | 16/17 | NM_012431.3 | ENSP00000496491 | P1 | ||
SEMA3E | ENST00000642232.1 | c.1855C>T | p.Arg619Cys | missense_variant | 16/17 | ENSP00000494064 | ||||
SEMA3E | ENST00000643441.1 | n.1840C>T | non_coding_transcript_exon_variant | 16/17 |
Frequencies
GnomAD3 genomes AF: 0.000138 AC: 21AN: 151838Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
21
AN:
151838
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000757 AC: 19AN: 251110Hom.: 0 AF XY: 0.0000884 AC XY: 12AN XY: 135724
GnomAD3 exomes
AF:
AC:
19
AN:
251110
Hom.:
AF XY:
AC XY:
12
AN XY:
135724
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000183 AC: 268AN: 1461106Hom.: 0 Cov.: 31 AF XY: 0.000173 AC XY: 126AN XY: 726876
GnomAD4 exome
AF:
AC:
268
AN:
1461106
Hom.:
Cov.:
31
AF XY:
AC XY:
126
AN XY:
726876
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000138 AC: 21AN: 151838Hom.: 0 Cov.: 32 AF XY: 0.000148 AC XY: 11AN XY: 74124
GnomAD4 genome
AF:
AC:
21
AN:
151838
Hom.:
Cov.:
32
AF XY:
AC XY:
11
AN XY:
74124
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
0
ESP6500EA
AF:
AC:
4
ExAC
AF:
AC:
12
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Uncertain:3
Uncertain significance, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Uncertain significance, no assertion criteria provided | literature only | OMIM | Oct 14, 2022 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Oct 27, 2023 | Observed in siblings with Kallman syndrome who were also heterozygous for a variant in the CHD7 gene, and observed in a patient with CHARGE syndrome who inherited the variant from an unaffected heterozygous parent (PMID: 25985275, 15235037); Published in vitro functional studies demonstrate a damaging effect on protein function (PMID: 25985275); In silico analysis supports that this missense variant does not alter protein structure/function; Variants in candidate genes are classified as variants of uncertain significance in accordance with ACMG guidelines (PMID: 25741868); This variant is associated with the following publications: (PMID: 29144511, 15235037, 25985275) - |
CHARGE syndrome Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Mar 02, 2023 | This sequence change replaces arginine, which is basic and polar, with cysteine, which is neutral and slightly polar, at codon 619 of the SEMA3E protein (p.Arg619Cys). This variant is present in population databases (rs143631464, gnomAD 0.01%). This missense change has been observed in individual(s) with CHARGE syndrome (PMID: 15235037). ClinVar contains an entry for this variant (Variation ID: 221681). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt SEMA3E protein function. Experimental studies have shown that this missense change affects SEMA3E function (PMID: 25985275). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
SEMA3E-related disorder Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Apr 16, 2024 | The SEMA3E c.1855C>T variant is predicted to result in the amino acid substitution p.Arg619Cys. This variant has been reported in two siblings with Kallmann syndrome; however, they also had a variant in CHD7 (p.Phe1019Cys) (Cariboni et al. 2015. PubMed ID: 25985275; Xu et al. 2018. PubMed ID: 29144511). It has also been reported in a child with CHARGE syndrome and their unaffected mother (Lalani et al. 2004. PubMed ID: 15235037). In vitro cell culture assays found this variant was unable to protect cells from cell death (Cariboni et al. 2015. PubMed ID: 25985275). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Benign
T;T;.;.
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
.;T;T;T
M_CAP
Benign
D
MetaRNN
Benign
T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
L;L;.;.
MutationTaster
Benign
D;D
PrimateAI
Benign
T
PROVEAN
Benign
N;.;N;.
REVEL
Benign
Sift
Uncertain
D;.;D;.
Sift4G
Uncertain
D;.;D;.
Polyphen
P;P;.;.
Vest4
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at